SPIA
DNA.WS

Steward Partners Investment Advisory’s Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share DNA.WS Stock Holding History

Steward Partners Investment Advisory’s Portfolio DNA.WS Stock Details DNA.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-200
Closed -$1 – 4154
2024
Q3 		$1 Sell
200
-13,500
-99% -$250 ﹤0.01% 3741
2024
Q2 		$386 Sell
13,700
-3,000
-18% -$161 ﹤0.01% 3496
2024
Q1 		$1.5K Hold
16,700
– – ﹤0.01% 3332
2023
Q4 		$1.76K Hold
16,700
– – ﹤0.01% 3224
2023
Q3 		$3.76K Sell
16,700
-1,000
-6% -$269 ﹤0.01% 2917
2023
Q2 		$4.64K Hold
17,700
– – ﹤0.01% 2812
2023
Q1 		$3.19K Buy
17,700
+4,000
+29% +$916 ﹤0.01% 2923
2022
Q4 		$2.74K Buy
13,700
+2,000
+17% +$858 ﹤0.01% 2947
2022
Q3 		$8K Buy
11,700
+1,000
+9% +$684 ﹤0.01% 2634
2022
Q2 		$6K Buy
10,700
+1,500
+16% +$951 ﹤0.01% 2731
2022
Q1 		$8K Buy
9,200
+3,000
+48% +$3.34K ﹤0.01% 2753
2021
Q4 		$14K Buy
6,200
+6,000
+3,000% +$19.4K ﹤0.01% 2485
2021
Q3 		$1K Buy
+200
New +$712 ﹤0.01% 3115

Other funds holding DNA.WS

AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
HIA
Harbor Investment Advisory Lutherville, Maryland $1.43B AUM 30.71% 1-Year Est. Return
NC
NewSquare Capital Newtown Square, Pennsylvania $1.35B AUM 34.37% 1-Year Est. Return

Steward Partners Investment Advisory's DNA.WS Position: Q4 2024 in Review

Steward Partners Investment Advisory sold out of Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share (DNA.WS) in Q4 2024, closing a stake of 200 shares — an estimated $1 sold.

Steward Partners Investment Advisory first reported a position in DNA.WS in Q3 2021 and held it in 13 quarters. The position peaked at $14K in Q4 2021. 3 funds tracked by Wall St. Rank hold DNA.WS as of Q4 2024.

  • Steward Partners Investment Advisory reported no remaining Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share position as of Q4 2024 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 200 Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share shares in Q4 2024, an estimated $1.
  • Steward Partners Investment Advisory first reported a position in Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share in Q3 2021 and held it in 13 quarters.
  • Steward Partners Investment Advisory's Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share position peaked at $14K in Q4 2021.
  • 3 funds tracked by Wall St. Rank held Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share as of Q4 2024.

Based on Steward Partners Investment Advisory's 13F filing for Q4 2024, filed 6 Feb 2025.